Your position:
m.limatoxi.com
>>
EN
>>
EN
>>
Formulation
>>
Received orphan drug recognition! Shanghai Pharmaceutical SPH4336 breakthrough liposarcoma
>> article
Received orphan drug recognition! Shanghai Pharmaceutical SPH4336 breakthrough liposarcoma
Editor:xuezhe Clicks:
0
Date:2023-3-31 15:49:12
Keyword:
Received orphan drug
Healthoo Information:
Received orphan drug recognition! Shanghai Pharmaceutical SPH4336 breakthrough liposarcoma
UserLogin
UserName：
Password：
The non-formal user may read the summary, the formal user can read the whole article。
please at once register the user of Heatlhoo.com
After registration, we will provide the sample reports and the more comprehensive consulting services for you.
UserName
Contact:
Title:
Mr.
Ms.
Password
Repeat password:
Mobile
Email
Verification code:
Company Name
E-mail:xuezhe@healthoo.com
Tel.:86-10-68032463
Our services:
China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information
Relative Information
THE BULK DRUG PARKS SCHEME
2022 global new drug inventory: "First-in-class" therapy accounted for...
Domestic anti-HIV new drug, Addison Pharmaceuticals "Inomitine Tablets...
Inventory in 2022: Overview of "Five Xiaoqiang" Export of Veterinary D...
The battle between Pfizer Gilead over COVID-19 drugs will continue
When is "water inverse" going on? Biogens ALS drug approval delayed to...
Market Report of Monoclonal Antibody Drugs in China (2022)
The Veterinary Drug Industry is Facing a Period of Opportunity for Cha...
Innovative drugs - Medium long-term growth still has more room for imp...
Chinas innovative drugs entering the global market is the future trend...
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463
map
